Estrella Immunopharma, Inc.
ESLA
Revenue
0.00
0.000.00%
-Assets
4.45M
▼-4.18M▼-48.41%
3 Months ChangeLiabilities
180.70k
▲42.21k▲30.48%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-20
Form 8-K
ID: 0001213900-24-071174
2024-08-06
Form 8-K
ID: 0001213900-24-065292
2024-07-02
Form 8-K
ID: 0001213900-24-058085
2024-05-15
Form 10-Q
ID: 0001213900-24-043126
2024-05-13
Form 8-K
ID: 0001213900-24-042444
2024-04-10
Form 8-K
ID: 0001213900-24-031716
2024-03-11
Form 8-K
ID: 0001213900-24-021186
2024-03-07
Form 8-K
ID: 0001213900-24-020566
2024-02-14
Form 10-Q
ID: 0001213900-24-014191
2024-02-02
Form 8-K
ID: 0001213900-24-009325